Kwo P - Search Results

1

Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant.

Yoshida EM, Kwo P, Agarwal K, Duvoux C, Durand F, Peck-Radosavljevic M, Lilly L, Willems B, Vargas H, Kumar P, Brown RS Jr, Horsmans Y, De-Oertel S, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault N, Rizzetto M, Müllhaupt B. Yoshida EM, et al. Among authors: kwo p. Ann Hepatol. 2017 May-Jun;16(3):375-381. doi: 10.5604/16652681.1235480. Ann Hepatol. 2017. PMID: 28425407 Free article.

2

Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation.

Horlander JC, Boyle N, Manam R, Schenk M, Herring S, Kwo PY, Lumeng L, Chalasani N. Horlander JC, et al. Among authors: kwo py. Am J Med Sci. 1999 Nov;318(5):304-7. doi: 10.1097/00000441-199911000-00004. Am J Med Sci. 1999. PMID: 10555092

3

A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.

Shakil AO, McGuire B, Crippin J, Teperman L, Demetris AJ, Conjeevaram H, Gish R, Kwo P, Balan V, Wright TL, Brass C, Rakela J. Shakil AO, et al. Among authors: kwo p. Hepatology. 2002 Nov;36(5):1253-8. doi: 10.1053/jhep.2002.36162. Hepatology. 2002. PMID: 12395337 Clinical Trial.

4

Combination therapy with lamivudine and famciclovir for chronic hepatitis B infection.

Shen H, Alsatie M, Eckert G, Chalasani N, Lumeng L, Kwo PY. Shen H, et al. Clin Gastroenterol Hepatol. 2004 Apr;2(4):330-6. doi: 10.1016/s1542-3565(04)00063-1. Clin Gastroenterol Hepatol. 2004. PMID: 15067628 Clinical Trial.

5

Management of hepatitis C infection after liver transplantation.

Alsatie M, Chalasani N, Kwo PY. Alsatie M, et al. Drugs. 2007;67(6):871-85. doi: 10.2165/00003495-200767060-00004. Drugs. 2007. PMID: 17428105 Review.

6

Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial.

Jacobson IM, Brown RS Jr, Freilich B, Afdhal N, Kwo PY, Santoro J, Becker S, Wakil AE, Pound D, Godofsky E, Strauss R, Bernstein D, Flamm S, Pauly MP, Mukhopadhyay P, Griffel LH, Brass CA; WIN-R Study Group. Jacobson IM, et al. Among authors: kwo py. Hepatology. 2007 Oct;46(4):971-81. doi: 10.1002/hep.21932. Hepatology. 2007. PMID: 17894303 Clinical Trial.

7

Impact of weight-based ribavirin with peginterferon alfa-2b in African Americans with hepatitis C virus genotype 1.

Jacobson IM, Brown RS Jr, McCone J, Black M, Albert C, Dragutsky MS, Siddiqui FA, Hargrave T, Kwo PY, Lambiase L, Galler GW, Araya V, Freilich B, Harvey J, Griffel LH, Brass CA; WIN-R Study Group. Jacobson IM, et al. Hepatology. 2007 Oct;46(4):982-90. doi: 10.1002/hep.21670. Hepatology. 2007. PMID: 17894323 Clinical Trial.

8

Intravenous interferon during the anhepatic phase of liver retransplantation and prevention of recurrence of cholestatic hepatitis C virus.

Kwo PY, Saxena R, Cummings OW, Tector AJ. Kwo PY, et al. Liver Transpl. 2007 Dec;13(12):1710-3. doi: 10.1002/lt.21295. Liver Transpl. 2007. PMID: 18044743 Free article.

9

Treatment of hepatitis C in liver transplant recipients.

Gordon FD, Kwo P, Vargas HE. Gordon FD, et al. Among authors: kwo p. Liver Transpl. 2009 Feb;15(2):126-35. doi: 10.1002/lt.21694. Liver Transpl. 2009. PMID: 19177439 Free article. Review.

10

Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.

Bacon BR, Shiffman ML, Mendes F, Ghalib R, Hassanein T, Morelli G, Joshi S, Rothstein K, Kwo P, Gitlin N. Bacon BR, et al. Among authors: kwo p. Hepatology. 2009 Jun;49(6):1838-46. doi: 10.1002/hep.22871. Hepatology. 2009. PMID: 19291790 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page